Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mills

Showing results (761-770 of 888) with videos related to

Pageof 89
Sort By:
Scientific Reports|November 3, 2025
IGF-1 regulates cancer cell immune evasion in prostate cancerAshwin M Nandakumar, Alessandro Barberis, Jinseon Kim, et al.
European Journal of Pharmacology|May 20, 1997
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonistsN M Rupniak, F D Tattersall, A R Williams, et al.
Nature Immunology|November 14, 2018
Metabolic reprogramming of natural killer cells in obesity limits antitumor responsesXavier Michelet, Lydia Dyck, Andrew Hogan, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Psychological Medicine|July 13, 2016
Psychological processes underlying the association between childhood trauma and psychosis in daily life: an experience sampling studyU Reininghaus, C Gayer-Anderson, L Valmaggia, et al.
Postgraduate Medical Journal|February 25, 2023
A Women in Medicine Trainees' Council: a model for women trainee professional developmentA Sofia C Warner, Nneka N Ufere, Naomi J Patel, et al.
Oncogene|September 27, 2016
Cell cycle-coupled expansion of AR activity promotes cancer progressionC McNair, A Urbanucci, C E S Comstock, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Disubstituted pyrimidines as Lck inhibitorsJulianne A Hunt, Richard T Beresis, Joung L Goulet, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Journal of Medicinal Chemistry|November 7, 1998
Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonistJ J Hale, S G Mills, M MacCoss, et al.
Pageof 89

Showing results (761-770 of 888) with videos related to

Sort By:
Pageof 89
Scientific Reports|November 3, 2025
IGF-1 regulates cancer cell immune evasion in prostate cancerAshwin M Nandakumar, Alessandro Barberis, Jinseon Kim, et al.
European Journal of Pharmacology|May 20, 1997
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonistsN M Rupniak, F D Tattersall, A R Williams, et al.
Nature Immunology|November 14, 2018
Metabolic reprogramming of natural killer cells in obesity limits antitumor responsesXavier Michelet, Lydia Dyck, Andrew Hogan, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Psychological Medicine|July 13, 2016
Psychological processes underlying the association between childhood trauma and psychosis in daily life: an experience sampling studyU Reininghaus, C Gayer-Anderson, L Valmaggia, et al.
Postgraduate Medical Journal|February 25, 2023
A Women in Medicine Trainees' Council: a model for women trainee professional developmentA Sofia C Warner, Nneka N Ufere, Naomi J Patel, et al.
Oncogene|September 27, 2016
Cell cycle-coupled expansion of AR activity promotes cancer progressionC McNair, A Urbanucci, C E S Comstock, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Disubstituted pyrimidines as Lck inhibitorsJulianne A Hunt, Richard T Beresis, Joung L Goulet, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Journal of Medicinal Chemistry|November 7, 1998
Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonistJ J Hale, S G Mills, M MacCoss, et al.
Pageof 89